Slideshow
Author(s):
You’ll want to get to bed early on Thursday, because you’ll have a very full week ahead. And even if you can't make #MDSCongress, October 5-9, 2018, get your highlights and Editor's Picks here.
Understanding the Therapeutic Potential of GT-02287 in GBA-Parkinson Disease
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
NORAPS Phase 2 Trial to Test Noradrenaline Reuptake Inhibitor Atomoxetine in PSP Apathy and Impulsivity
Continued Progress in Phase 1 Study of Antisense Oligonucleotide ION464 in MSA
NeuroVoices: Lucia Ricciardi, MD, PhD, on Addressing Neuropsychiatric Symptom Management in Parkinson Disease
Patients Highly Recommend Continuous Subcutaneous Apomorphine Infusion for Parkinson Disease, Survey Says